Completed PHASE4 INTERVENTIONAL 2-arm NCT01414842

HFR A-equilibrium on Cardiovascular Stability (AIMS)

Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients

Sponsor: Azienda Ospedaliera di Lecco

Conditions Hypotension

Interventions Automated sodium profiling in endogenous hemodiafiltration Standard sodium dialysate

Updated 7 times since 2017 Last updated: Aug 26, 2011 Started: Apr 30, 2007 Primary completion: Oct 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypotension and is currently completed. Azienda Ospedaliera di Lecco leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Oct 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera di Lecco
Centre Pasteur Vallery Radot
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Data source: Azienda Ospedaliera di Lecco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ancona, Italy , Barcelona, Spain , Bologna, Italy , Brussels, Belgium , Cirié, Italy , Foggia, Italy , Novara, Italy , Paris, France , Rostock, Germany , San Giovanni Rotondo, Italy and 2 more locations